"Costello Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Rare congenital disorder with multiple anomalies including: characteristic dysmorphic craniofacial features, musculoskeletal abnormalities, neurocognitive delay, and high prevalence of cancer. Germline mutations in H-Ras protein can cause Costello syndrome. Costello syndrome shows early phenotypic overlap with other disorders that involve MAP KINASE SIGNALING SYSTEM (e.g., NOONAN SYNDROME and cardiofaciocutaneous syndrome).
| Descriptor ID |
D056685
|
| MeSH Number(s) |
C05.660.207.219 C16.131.077.256 C16.320.185
|
| Concept/Terms |
Costello Syndrome- Costello Syndrome
- Syndrome, Costello
- Faciocutaneoskeletal Syndrome
- Faciocutaneoskeletal Syndromes
- Syndrome, Faciocutaneoskeletal
- Syndromes, Faciocutaneoskeletal
- FCS Syndrome
- FCS Syndromes
- Syndrome, FCS
- Syndromes, FCS
|
Below are MeSH descriptors whose meaning is more general than "Costello Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Costello Syndrome".
This graph shows the total number of publications written about "Costello Syndrome" by people in this website by year, and whether "Costello Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Costello Syndrome" by people in Profiles.
-
Costello syndrome: Clinical phenotype, genotype, and management guidelines. Am J Med Genet A. 2019 09; 179(9):1725-1744.
-
Phenotypic analysis of individuals with Costello syndrome due to HRAS p.G13C. Am J Med Genet A. 2011 Apr; 155A(4):706-16.
-
High incidence of progressive postnatal cerebellar enlargement in Costello syndrome: brain overgrowth associated with HRAS mutations as the likely cause of structural brain and spinal cord abnormalities. Am J Med Genet A. 2010 May; 152A(5):1161-8.